CLL Society On Demand: COVID-19 Virtual Community Meeting: COVID-19: Are Monoclonal Antibodies What the CLL Community Has Been Waiting For? Join us for this COVID-19 Virtual Community Meeting, CLL Society’s continuing series, providing information to empower our CLL patient and... December 2, 2021Archived Education, COVID-19By Brad Hedrick
Holiday Cheer Without the Fear for CLL/SLL Patients CLL Society is encouraging all chronic lymphocytic leukemia patients who received the Moderna or Pfizer vaccines to promptly arrange for... November 22, 2021COVID-19, Official Statements and Press ReleasesBy Brad Hedrick
A CLL (Chronic Lymphocytic Leukemia) Patient Tell Her Story About Being Immune Compromised During the COVID-19 Pandemic and Accessing Regen-Cov (Casirivimab and Imdevimab) for Protection For CLL/SLL patients to feel safer reentering a world where SARS-CoV-2 remains an active threat, we need more help than... November 18, 2021C19 - Updates, COVID-19By Brad Hedrick
Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate This is not CLL/SLL specific but wouldn't any immunocompromised (IC) patient feel safer if they knew there was a five-day... November 18, 2021C19 - Updates, COVID-19, NewsBy Brad Hedrick
Pfizer’s Antiviral (Paxlovid) Slashes COVID-19 Hospitalizations For CLL/SLL patients to feel safer reentering a world where SARS-CoV-2 remains an active threat, we need more help than... November 18, 2021C19 - Updates, COVID-19By Brad Hedrick
New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (Casirivimab and Imdevimab) Provides Long-Term Protection Against COVID-19: What This Might Mean for CLL/SLL patients The Nov. 8th press release from Regeneron offer the promise that Casirivimab and Imdevimab also may be effective for pre-exposure... November 12, 2021C19 - Updates, COVID-19, NewsBy Brad Hedrick
Dr. Koffman’s Radio Interview on the Impact of COVID-19 on the Immunocompromised, Including CLL/SLL Patients Health Professional Radio (HPR) interviewed Dr. Brian Koffman on this critical subject that is so near and dear to his... November 12, 2021C19 - Updates, COVID-19, NewsBy Brad Hedrick
Why Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Patients Need Passive Immunity Dr. Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd, a co-founder and Chief Medical Officer of the CLL Society, Inc.,... November 5, 2021C19 - Updates, COVID-19, NewsBy Brad Hedrick
Dr. Koffman Discusses Impact of COVID Pandemic on Care of CLL Patients Dr. Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd, a co-founder and Chief Medical Officer of the CLL Society, Inc.,... November 2, 2021C19 - Updates, COVID-19, NewsBy Brad Hedrick
Monoclonal Antibodies for COVID-19 Pre-exposure Prophylaxis Can’t Come Fast Enough for Some People, Including those with CLL (Chronic Lymphocytic Leukemia) Please take a look at this strong article published in the prestigious medical journal, JAMA (Journal of the American Medical... October 28, 2021C19 - Updates, COVID-19, NewsBy Brad Hedrick
